BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16597831)

  • 1. Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design.
    Clark LA; Boriack-Sjodin PA; Eldredge J; Fitch C; Friedman B; Hanf KJ; Jarpe M; Liparoto SF; Li Y; Lugovskoy A; Miller S; Rushe M; Sherman W; Simon K; Van Vlijmen H
    Protein Sci; 2006 May; 15(5):949-60. PubMed ID: 16597831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IsAb: a computational protocol for antibody design.
    Liang T; Chen H; Yuan J; Jiang C; Hao Y; Wang Y; Feng Z; Xie XQ
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33876197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of canonical structure determining residues on antibody affinity and stability.
    Clark LA; Demarest SJ; Eldredge J; Jarpe MB; Li Y; Simon K; van Vlijmen HW
    J Struct Biol; 2014 Feb; 185(2):223-7. PubMed ID: 23994046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the complex of the variable domain of antibody D1.3 and turkey egg white lysozyme: a novel conformational change in antibody CDR-L3 selects for antigen.
    Braden BC; Fields BA; Ysern X; Goldbaum FA; Dall'Acqua W; Schwarz FP; Poljak RJ; Mariuzza RA
    J Mol Biol; 1996 Apr; 257(5):889-94. PubMed ID: 8632472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity improvement of a therapeutic antibody by structure-based computational design: generation of electrostatic interactions in the transition state stabilizes the antibody-antigen complex.
    Kiyoshi M; Caaveiro JM; Miura E; Nagatoishi S; Nakakido M; Soga S; Shirai H; Kawabata S; Tsumoto K
    PLoS One; 2014; 9(1):e87099. PubMed ID: 24475232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y; Li H; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity Improvement of a Cancer-Targeted Antibody through Alanine-Induced Adjustment of Antigen-Antibody Interface.
    Yamashita T; Mizohata E; Nagatoishi S; Watanabe T; Nakakido M; Iwanari H; Mochizuki Y; Nakayama T; Kado Y; Yokota Y; Matsumura H; Kawamura T; Kodama T; Hamakubo T; Inoue T; Fujitani H; Tsumoto K
    Structure; 2019 Mar; 27(3):519-527.e5. PubMed ID: 30595454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutational analysis of binding interactions in an antigen-antibody protein-protein complex.
    Dall'Acqua W; Goldman ER; Lin W; Teng C; Tsuchiya D; Li H; Ysern X; Braden BC; Li Y; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 1998 Jun; 37(22):7981-91. PubMed ID: 9609690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.
    Decanniere K; Desmyter A; Lauwereys M; Ghahroudi MA; Muyldermans S; Wyns L
    Structure; 1999 Apr; 7(4):361-70. PubMed ID: 10196124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the alpha1beta1 integrin I domain in complex with an antibody Fab fragment.
    Karpusas M; Ferrant J; Weinreb PH; Carmillo A; Taylor FR; Garber EA
    J Mol Biol; 2003 Apr; 327(5):1031-41. PubMed ID: 12662928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of the immunological evolution of antibody 28B4.
    Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG
    Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cation-π, amino-π, π-π, and H-bond interactions stabilize antigen-antibody interfaces.
    Dalkas GA; Teheux F; Kwasigroch JM; Rooman M
    Proteins; 2014 Sep; 82(9):1734-46. PubMed ID: 24488795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen bonding and solvent structure in an antigen-antibody interface. Crystal structures and thermodynamic characterization of three Fv mutants complexed with lysozyme.
    Fields BA; Goldbaum FA; Dall'Acqua W; Malchiodi EL; Cauerhff A; Schwarz FP; Ysern X; Poljak RJ; Mariuzza RA
    Biochemistry; 1996 Dec; 35(48):15494-503. PubMed ID: 8952503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv).
    Tu C; Terraube V; Tam AS; Stochaj W; Fennell BJ; Lin L; Stahl M; LaVallie ER; Somers W; Finlay WJ; Mosyak L; Bard J; Cunningham O
    J Biol Chem; 2016 Jan; 291(3):1267-76. PubMed ID: 26515064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical basis for the affinity maturation of a camel single domain antibody.
    De Genst E; Handelberg F; Van Meirhaeghe A; Vynck S; Loris R; Wyns L; Muyldermans S
    J Biol Chem; 2004 Dec; 279(51):53593-601. PubMed ID: 15383540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
    Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
    PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into the evolution of an antibody combining site.
    Wedemayer GJ; Patten PA; Wang LH; Schultz PG; Stevens RC
    Science; 1997 Jun; 276(5319):1665-9. PubMed ID: 9180069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantial energetic improvement with minimal structural perturbation in a high affinity mutant antibody.
    Midelfort KS; Hernandez HH; Lippow SM; Tidor B; Drennan CL; Wittrup KD
    J Mol Biol; 2004 Oct; 343(3):685-701. PubMed ID: 15465055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.